North America
ContraFect Corporation Announces Third Quarter 2014 Results
ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant infectious diseases, today announced results for the third quarter ended September 30, 2014. The Company closed its initial public offering (IPO) on August 1, 2014.
U.S. data points to strong spending ahead of holiday shopping frenzy
Most U.S. retailers reported strong sales in October, a sign American consumers were spending with more gusto and could help keep the economy growing at a brisk pace.
Google Glass future clouded as some early believers lose faith
After two years of popping up at high-profile events sporting Google Glass, the gadget that transforms eyeglasses into spy-movie worthy technology, Google co-founder Sergey Brin sauntered bare-faced into a Silicon Valley red-carpet event on Sunday.
UBS looking to take back bonuses from forex traders
UBS AG, among the six banks fined this week for their role in the global foreign exchange scandal, is looking at clawing back bonuses from its traders.